Evaluation of the efficacy of low-level laser in improving  the symptoms of burning mouth syndrome by Arbabi-Kalati, Fateme et al.
J Clin Exp Dent. 2015;7(4):e524-7.                                                                                                                                               Efficacy of low-level laser on burning mouth syndrome
e524
Journal section: Oral Medicine and Pathology                            
Publication Types: Research
Evaluation of the efficacy of low-level laser in improving 
the symptoms of burning mouth syndrome
Fateme Arbabi-Kalati 1,2, Nour-Mohammad Bakhshani 3, Maryam Rasti 4
1 Oral Medicine Department, Zahedan University of Medical Sciences, Zahedan, Iran
2  Oral and Dental Disease Research Center, Zahedan University of Medical Sciences
3 Research Center for Children and Adolescent’s Health, Baharan psychiatric center Zahedan University of Medical Sciences, 
Zahedan, Iran
4 Dentist
Correspondence:
Oral and dental disease research center
Zahedan University of Medical Sciences
Azadegan street
Zahedan,Iran 
arbabi@zaums.ac.ir
Received: 09/01/2015
Accepted: 24/05/2015
Abstract 
Background: Burning mouth syndrome (BMS) is common condition that affects menopause women, patients suffer 
from sever burning sensation. Up to now there is no definitive treatment for this disease. Present study was undertaken 
to evaluate the efficacy of low-level laser (LLL) in improving the symptoms of burning mouth syndrome.
Material and Methods: Twenty patients with BMS were enrolled in this study; they were divided in two groups ran-
domly. In the laser group, in each patient, 10 areas on the oral mucosa were selected and underwent LLL irradiation 
at a wavelength of 630 nm, and a power of 30 mW for 10 seconds twice a week for 4 weeks. In the placebo group, 
silent/off laser therapy was carried out during the same period in the same areas. Burning sensation and quality of 
life were evaluated.
Results: Burning sensation severity and quality of life in the two groups after intervention were different significant 
statistically, (P= 0.004, P= 0.01 respectively) .Patients in laser group had better results.
Conclusions: It can be concluded that low level laser might decrease the intensity of burning mouth syndrome.
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Introduction
Burning mouth syndrome (BMS) is a common condition, 
with symptoms such as pain and a burning sensation of 
the oral mucosa in the absence of manifestations of any 
local condition. The condition predominantly affects the 
tongue, especially the anterior two-thirds of the tongue 
(1,2). However, it can affect other areas of the oral cavi-
ty, too, including the lips, the buccal mucosa, the floor 
of the mouth, the gingiva and the hard palate (1). The 
symptoms vary from mild to severe in intensity. Patients 
complain of xerostomia, lack of or absence of taste or 
altered taste sensation (1). Despite a large number of stu-
dies, the true nature of BMS is still controversial and is 
shrouded in mystery and there is no universal consensus 
on the diagnosis, etiology and treatment of BMS (2). In-
ternational Association for the Study of Pain defines this 
condition as “burning pain in the tongue or other oral 
mucous membrane associated with normal signs and la-
boratory findings lasting at least 4-6 months” (3).
It appears the prevalence of BMS is higher in middle-
Arbabi-Kalati F, Bakhshani NM, Rasti M. Evaluation of the efficacy of 
low-level laser in improving the symptoms of burning mouth syndrome. 
J Clin Exp Dent. 2015;7(4):e524-7.
http://www.medicinaoral.com/odo/volumenes/v7i4/jcedv7i4p524.pdf
Article Number: 52298                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Pubmed
Pubmed Central® (PMC)
Scopus
DOI® System
J Clin Exp Dent. 2015;7(4):e524-7.                                                                                                                                              Efficacy of low-level laser on burning mouth syndrome
e525
aged women and after menopause. The female-to-male 
ratio has been reported from 3:1 to 16:1 (4). The patients 
usually wake up in the morning without any pain and the 
symptoms increase in severity during the day until the 
afternoon. Many patients suffer from this condition for a 
long time, persisting for many months or years (4).
The treatment of BMS is usually symptomatic and use 
of low doses of benzodiazepines, clonazepam and tricy-
clic antidepressants might be effective (5,6). However, 
long-term treatment with such medications might result 
in xerostomia, aggravating the patients’ pain perception 
(1,4). A number of researchers have reported a definite 
decrease in pain severity with the application of low-
level laser beams and have shown that it can decrease 
the severity of pain in stomatitis and BMS. 
Considering the small sample sizes in the studies above 
and use of laser beams with varying wavelengths and 
energy levels and the discrepancies between the results 
of some studies, the present study was undertaken to 
evaluate the efficacy of low-level laser in improving the 
symptoms of burning mouth syndrome. Since none of 
the studies above have evaluated the quality of life of 
such patients, in the present study the general quality of 
life of these patients was evaluated, too. 
Material and Methods 
The present clinical trial was approved by the Ethics 
Committee of Zahedan University of Medical Sciences 
and was registered at the website of Iranian Clinical Trials 
at www.irct.ir under the code IRCT201312173133N7. 
All the patients signed an informed consent form before 
being included in the study. The subjects were selected 
from the patients with burning mouth syndrome, who re-
ferred to Zahedan Faculty of Dentistry. The criteria used 
to diagnose BMS consisted of the following: 1) burning 
sensation in all or a part of the oral cavity with or wi-
thout symptoms such as a change in taste sensation for 
at least 4 months; 2) normal oral mucosa without any 
lesion; and 3) absence of any local or systemic factors 
which produce the same symptoms. 
Exclusion criteria consisted of any known systemic con-
dition, patients under 18, pregnancy, smoking, patients 
with oral lesions and patients not signing the informed 
consent form. The patients were examined before the 
study and the severity of burning sensation was evalua-
ted based on numeric rating scale  (NRS), in which zero 
indicated absence of burning sensation and a score of 
10 indicated the most severe burning sensation experien-
ced by the patient. Each patient was asked to rate his/her 
burning sensation severity from zero to 10. The patients 
were divided into laser and placebo groups using block 
randomization.
In the laser group, in each patient, 10 areas on the oral 
mucosa, 2 areas on the buccal mucosa on each side, 2 
areas on the tongue, 2 areas on the floor of the mouth, 1 
area on the soft palate and 1 area on the hard palate were 
selected and underwent LLL irradiation at a wavelength 
of 630 nm, and a power of 30 mW for 10 seconds twice a 
week for 2 weeks. To this end, Iodine-Gallium-Aresnide 
laser of Mustange laser device (Russia) was used. The 
laser dose for each area was 1 j/cm2. 
In the placebo group, silent/off laser therapy was carried 
out during the same period in the same areas. All the 
patients wore protective glasses to protect their eyes 
against laser injuries and to blind the patients to the type 
of treatment modality used. 
All the patients were examined by an oral medicine spe-
cialist before laser irradiations and their pain severity 
was recorded. In addition, a questionnaire was comple-
ted for each patient for quality of life. The validity and 
reproducibility of the Persian version of the questionnai-
re have been evaluated and confirmed by Motallebenjad 
et al. (7). 
Each patient was treated for 2 weeks. At the end of the 
treatment period, all the patients were examined once 
again and their pain severity was recorded. Then the 
questionnaire for quality of life was completed again. All 
evaluations  of pain and quality of life (before and after 
treatment) were done by blind oral medicine specialist.
Data were analyzed with SPSS 18. The means of bur-
ning sensation severity scores of the patients before and 
after intervention were evaluated by Mann-Whitney U 
test. Statistical significance was defined at P<0.05. 
Results
Twenty female patients (10 in the laser group and 10 in 
the placebo group) were included in the present study, 
age and duration of disease are  showed in table 1; there 
was no statistically significant differences between two 
groups. Table 2 presents the scores of burning sensation 
severity and quality of life in the two groups before and 
after intervention. As table 2 have been shown there were 
no statistically significant differences between two groups 
before intervention but after intervention burning sensa-
tion severity was lower and quality of life was better in 
laser group, there were statistically significant differences 
between two groups. (P= 0.004, P= 0.01 respectively).
Discussion
The results of the present study showed that use of low-
level laser (LLL) in patients with BMS results in a de-
crease in pain severity, though it does not relieve pain 
completely. 
A limited number of studies have evaluated the effect of 
LLL on BMS and almost all these studies have reported 
a decrease in burning sensation severity after treatment, 
consistent with the results of the present study (4,8,9). 
In a pilot study by Romeo et al. (4) in 2010 the effect of 
LLL was evaluated on 25 patients with BMS. Patients 
were irradiated with double diode laser 650 nm and 910 
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Table 1. Demographic characteristics of patients.
Laser
Mean ±SD
Placebo
Mean ±SD
P value
Age
(year)
47.2±5.3 46.6±4.6 0.7
Duration of disease 
(month)
13.4±7.4(6-30) 15.5±0.1(6-36) 0.6


               Variable
Group
Burning sensation 
before intervention
Burning sensation 
after intervention
Quality of life 
before intervention
Quality of life after 
intervention
Laser 8±2.3  3.6±3  27.8±12  12.8±11.4
Placebo 8.2±1.7  8±1.5  28.3±11.9  28.6±11.5
P value 0.4  0.004  0.9  0.01
Table 2. The severities of burning sensation and quality of life in the two groups before and after treatment.
nm, with a fluence of 0.53 J/cm for 15 minutes twice a 
week for 4 weeks. All the patients exhibited a decrease 
in burning sensation severity and all of them attributed 
it to the effect of LLL; 68% of patients exhibited a real 
decrease in pain severity and pain did not aggravate in 
any of the patients. 
In another study by Kato et al. (8) in 2010, 11 patients 
were irradiated with infrared laser with a wavelength of 
790 nm for 3 consecutive weeks; 84% of the patients 
reported improvements after receiving LLL . 
In 2011, Yang and Huang (10) made an effort to treat 
BMS with LLL. Seventeen patients were irradiated 1-7 
times with 800-nm wavelength diode laser and average 
power of 1.5 W/cm2; there was a 46.7% decrease in pain 
severity . 
In another study in 2011, Dos Santos (9) evaluated the 
effect of LLL; A continuous wavelength of 660 nm, 
power 0.8 J/point on BMS for 10 weeks. All 10 the pa-
tients recovered from the condition and there was a 58% 
decrease in pain severity .
Pezelj-Ribarić et al. (1) in 2012 determined the salivary 
levels of proinflammatory cytokines in patients with 
BMS before and after LLL irradiation and reported a 
significant decrease in un-stimulated salivary levels of 
two proinflammatory factors of TNF-α and IL-6 four 
weeks after treatment with laser; however, the patients’ 
burning sensation did not decrease. 
The mechanism of the effect of LLL on decreasing pain 
and burning sensation severity is unknown; however, 
some studies have shown that there are three main me-
chanisms for the analgesic effects of LLL, including 
induction of the release of endogenous opiates, an in-
crease in pain threshold and regulation of the release of 
pain mediators such as bradykinin and histamine (11). 
In addition, some studies have shown that LLL irradia-
tion changes the rate of action potential conductance 
along the nerves. LLL retards pain impulse conductance 
through the autonomous nervous system, regulation of 
serotonin and norepinephrine levels and by increasing 
the pain threshold. 
The results of the present study show that using LLL sig-
nificantly decrease burning sensation severity in patients 
who suffer from BMS, but the present study had some 
limitations, including the small sample size and long du-
ration of the application of LLL, which decreases the 
cooperation of patients. Further research is required to 
validate our findings. 
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